Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Post Market
Current status date:
2011-10-19
Original market date: See footnote 1
1973-12-31
Product name:
BLENOXANE PWS 15UNIT
DIN:
00258482
Product Monograph/Veterinary Labelling:
Date:
2010-12-03
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB
300
2344 Boul. Alfred Nobel
Montreal
Quebec
Canada
H4S 0A4
Class:
Human
Dosage form(s):
Powder For Solution
Route(s) of administration:
Intramuscular , Intravenous
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
10:00.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
L01DC01 BLEOMYCIN
Active ingredient group (AIG) number:See footnote5
0105871001
| Active ingredient(s) | Strength |
|---|---|
| BLEOMYCIN SULFATE | 15 UNIT / AMP |